Divergent detection rates of fecal immunochemical test and questionnaire-based risk assessment for detecting proximal and distal advanced colorectal adenomas

Divergent detection rates of fecal immunochemical test and questionnaire-based risk assessment for detecting proximal and distal advanced colorectal adenomas

Bibliographic Details
Main Authors:	Hong-Da Chen, Ming Lu, Yu-Han Zhang, Min Dai, Jing Ni
Format:	Article
Language:	English
Published:	Wolters Kluwer 2021-03-01
Series:	Chinese Medical Journal
Online Access:	http://journals.lww.com/10.1097/CM9.0000000000001346

Similar Items

Fecal Immunochemical Tests Detect Screening Participants with Multiple Advanced Adenomas Better than T1 Colorectal Cancers
by: Anton Gies, et al.
Published: (2021-02-01)

Reusing a prepaid health plan’s fecal immunochemical tests for microbiome associations with colorectal adenoma
by: James J. Goedert, et al.
Published: (2022-08-01)

Comparison of colonoscopy after colonic diverticulitis and positive fecal immunochemical tests for the detection of colorectal neoplasia
by: Dai Nakamatsu, et al.
Published: (2021-02-01)

Risk factors of advanced colorectal neoplasia in fecal immunochemical test negative patients
by: Tomoyuki Kawada
Published: (2022-06-01)

Evaluation of Fecal Immunochemical Tests for Colorectal Cancer Screening
by: Jeanette M. Daly, et al.
Published: (2013-10-01)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
by: Dong Ju Kim, et al.
Published: (2018-10-01)

Fecal Immunochemical Testing and the Risk of Advanced Colorectal Neoplasia: A Difference-In-Difference Analysis
by: Guanglu Zhang, et al.
Published: (2024-01-01)

Comparison between the Effectiveness Fecal Immunochemical Test and Colonoscopy As A Tool For Colorectal Cancer Early Detection
by: Yossi Andila, et al.
Published: (2022-03-01)

Feasibility of quantification based on novel evaluation with stool DNA and fecal immunochemical test for colorectal cancer detection
by: Hongli Xu, et al.
Published: (2022-08-01)

Optimal cut-off value for detecting colorectal cancer with fecal immunochemical tests according to age and sex.
by: Mercedes Vanaclocha-Espi, et al.
Published: (2021-01-01)

Fecal Multidimensional Assay for Non-Invasive Detection of Colorectal Cancer: Fecal Immunochemical Test, Stool DNA Mutation, Methylation, and Intestinal Bacteria Analysis
by: Shaobo Mo, et al.
Published: (2021-02-01)

Head-to-head comparison of the test performance of self-administered qualitative vs. laboratory-based quantitative fecal immunochemical tests in detecting colorectal neoplasm
by: Ming Lu, et al.
Published: (2021-06-01)

Clinical Utility of Fecal Immunochemical Transferrin Test in Gastrointestinal Bleeding Detection
by: Jong-Mi Lee, et al.
Published: (2018-09-01)

Performance of the fecal immunochemical test for colorectal cancer and advanced neoplasia in individuals under age 50
by: Emily Heer, et al.
Published: (2023-04-01)

Detection of colorectal serrated polyps by stool DNA testing: comparison with fecal immunochemical testing for occult blood (FIT).
by: Russell I Heigh, et al.
Published: (2014-01-01)

Performance of the Fecal Immunochemical Test in Detecting Advanced Colorectal Neoplasms and Colorectal Cancers in People Aged 40–49 Years: A Systematic Review and Meta-Analysis
by: Jen-Hao Yeh, et al.
Published: (2023-05-01)

Colorectal cancer screening using immunochemical fecal occult blood test
by: Tan, Mun Chieng, et al.
Published: (2017)

Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
by: Efrat L. Amitay, et al.
Published: (2019-03-01)

Diagnostic Accuracy Of Fecal Occult Blood Tests For Detecting Proximal Versus Distal Colorectal Neoplasia: A Systematic Review And Meta-Analysis
by: Lu M, et al.
Published: (2019-10-01)

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
by: P. H. A. Wisse, et al.
Published: (2022-12-01)

Interval Cancer Rate and Diagnostic Performance of Fecal Immunochemical Test According to Family History of Colorectal Cancer
by: Yoon Suk Jung, et al.
Published: (2020-10-01)

Clinical risk stratification model for advanced colorectal neoplasia in persons with negative fecal immunochemical test results.
by: Yoon Suk Jung, et al.
Published: (2018-01-01)

New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population.
by: Marta Malagón, et al.
Published: (2020-01-01)

Polyprev: Randomized, Multicenter, Controlled Trial Comparing Fecal Immunochemical Test with Endoscopic Surveillance after Advanced Adenoma Resection in Colorectal Cancer Screening Programs: A Study Protocol
by: Cristina Regueiro, et al.
Published: (2021-08-01)

The Diagnostic Accuracy of a Fecal Immunochemical Test in Detecting Colorectal Cancer and Advanced Precancerous Colorectal Neoplasia in Patients with Iron Deficiency: A Protocol for Systematic Review and Meta-Analysis
by: Jennifer Pham, et al.
Published: (2023-01-01)

Utility of Fecal Immunochemical Test in Screening for Colorectal Cancer in Egyptian Individuals with Family History of Advanced Colonic Neoplasia
by: Ahmed Alwassief, et al.
Published: (2023-01-01)

PROXIMAL SERRATED POLYP DETECTION RATE: A COMPLEMENTARY QUALITY INDICATOR FOR ADENOMA DETECTION RATE?
by: Fernando Antônio Vieira LEITE, et al.
Published: (2020-12-01)

Timing and Risk Factors for a Positive Fecal Immunochemical Test in Subsequent Screening for Colorectal Neoplasms.
by: Tsung-Hsien Chiang, et al.
Published: (2015-01-01)

Cost-effectiveness analysis of colonoscopy and fecal immunochemical testing for colorectal cancer screening in China
by: Yinan Ren, et al.
Published: (2022-08-01)

Comment on “Positive fecal immunochemical test results are associated with non-colorectal cancer mortality”
by: Yong Eun Park
Published: (2023-03-01)

Combining the Fecal Immunochemical Test with a Logistic Regression Model for Screening Colorectal Neoplasia
by: Feiyuan Liu, et al.
Published: (2021-03-01)

Combining methylated SDC2 test in stool DNA, fecal immunochemical test, and tumor markers improves early detection of colorectal neoplasms
by: Tao Zeng, et al.
Published: (2023-08-01)

The impact of endoscopist performance and patient factors on distal adenoma detection and colorectal cancer incidence
by: Sharon Power, et al.
Published: (2024-01-01)

Accuracy of a faecal immunochemical test in patients under colonoscopy surveillance of colorectal adenoma and cancer
by: Louise Olsson, et al.
Published: (2023-06-01)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening.
by: S Lucas Goede, et al.
Published: (2017-01-01)

Variable Endoscopist performance in proximal and distal adenoma detection during colonoscopy: a retrospective cohort study
by: Paul James, et al.
Published: (2018-05-01)

Fecal Microbiota Characteristics of Patients with Colorectal Adenoma Detected by Screening: A Population-based Study
by: James J. Goedert, et al.
Published: (2015-06-01)

Combination of Different Fecal Immunochemical Tests in Colorectal Cancer Screening: Any Gain in Diagnostic Performance?
by: Anton Gies, et al.
Published: (2019-01-01)

Feasibility and performance of the fecal immunochemical test (FIT) for average-risk colorectal cancer screening in Nigeria.
by: Gregory C Knapp, et al.
Published: (2021-01-01)

MicroRNA-based signature for diagnosis and prognosis of colorectal cancer using residuum of fecal immunochemical test
by: Chia-Chun Chen, et al.
Published: (2023-02-01)